NEW YORK (Reuters Breakingviews) - Rampaging animal spirits have given birth to a biotechnology unicorn. It's apt that a stellar year for initial public offerings in the sector will be capped by its biggest float ever. Juno Therapeutics is a year old...
Company: DENDREON CORP; BELLICUM PHARMACEUTICALS INC; NOVARTIS INC; KITE PHARMA INC
News Subject: (Corporate Funding (1XO17); Health & Family (1HE30); Stock Offerings (1ST44); Funding Instruments (1FU41); Initial Public Offerings (IPOs) (1IN65); Equity Instruments (1EQ90))
Industry: (Internal Medicine (1IN54); Oncology & Hematology (1ON95); Immunology (1IM66); Healthcare (1HE06); Investment Management (1IN34); Allergy & Immunology (1AL96); Securities Investment (1SE57); Financial Services (1FI37); Healthcare Practice Specialties (1HE49))
Keywords: securities; capmarket; SecOfferings (MCC:OEC); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)